Glen Eagle Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.9K Hold
197
﹤0.01% 519
2025
Q1
$25.1K Buy
197
+1
+0.5% +$128 ﹤0.01% 514
2024
Q4
$26K Hold
196
﹤0.01% 520
2024
Q3
$28.6K Sell
196
-615
-76% -$89.7K ﹤0.01% 520
2024
Q2
$111K Hold
811
0.02% 290
2024
Q1
$111K Hold
811
0.02% 292
2023
Q4
$110K Buy
811
+265
+49% +$36K 0.02% 285
2023
Q3
$66.8K Sell
546
-25
-4% -$3.06K 0.02% 342
2023
Q2
$72.5K Hold
571
0.02% 334
2023
Q1
$73.7K Hold
571
0.02% 318
2022
Q4
$75K Buy
571
+375
+191% +$49.2K 0.02% 314
2022
Q3
$22.9K Hold
196
0.01% 464
2022
Q2
$23K Hold
196
0.01% 475
2022
Q1
$25.5K Hold
196
0.01% 474
2021
Q4
$29.9K Hold
196
0.01% 453
2021
Q3
$31.6K Buy
196
+105
+115% +$17K 0.01% 458
2021
Q2
$14.8K Hold
91
﹤0.01% 616
2021
Q1
$13.6K Sell
91
-60
-40% -$9K ﹤0.01% 604
2020
Q4
$22.9K Hold
151
0.01% 472
2020
Q3
$20.4K Hold
151
0.01% 461
2020
Q2
$20.6K Hold
151
0.01% 434
2020
Q1
$16.2K Hold
151
0.01% 435
2019
Q4
$18.1K Buy
151
+1
+0.7% +$120 0.01% 480
2019
Q3
$15K Hold
150
0.01% 450
2019
Q2
$16.4K Hold
150
0.01% 428
2019
Q1
$16.8K Hold
150
0.01% 405
2018
Q4
$14.5K Hold
150
0.01% 408
2018
Q3
$18.3K Hold
150
0.01% 390
2018
Q2
$16.5K Hold
150
0.01% 389
2018
Q1
$16K Hold
150
0.01% 369
2017
Q4
$16K Hold
150
0.01% 368
2017
Q3
$16.7K Hold
150
0.02% 362
2017
Q2
$15.5K Hold
150
0.01% 336
2017
Q1
$14.7K Sell
150
-12
-7% -$1.17K 0.01% 324
2016
Q4
$14.3K Buy
+162
New +$14.3K 0.01% 308